Sublingual Nitroglycerin in Managing Retained Placenta: A Placebo-controlled Trial
Background: Retained placenta poses significant surgical and hemorrhagic risks, influencing 1%–3% of births. Because it relaxes the uterus, a nitric oxide donor substance called nitroglycerin (NTG) has gained attention as a possible treatment. Objectives: This study aimed to evaluate the safety and...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2026-01-01
|
| coleção: | Medical Journal of Babylon |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.4103/MJBL.MJBL_889_24 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|